Dame Emma Walmsley has been CEO at GSK since 2017. This week has kicked off with the unexpected news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by ...

Emma Walmsley's last set of financial results as GSK's chief executive has gone swimmingly, with better-than-expected sales growth that has allowed the company to raise its full-year forecasts. Group ...

GSK has lifted its sales and profits targets after a boost from HIV and oncology drugs as chief executive Dame Emma Walmsley prepares to leave the pharmaceutical giant. Shares in the company rose on ...

Alex Walmsley is determined to make the most of his unlikely England recall and play a part in an historic Ashes series win over Australia, starting at Wembley on Saturday. Having not played ...

Emma Walmsley, who is set to step down from her role at the end of the year, said that leaders should focus on improving things during their tenure. GSK CEO Emma Walmsley has said she finds it ...

Elliana Walmsley picked my Halloween costume bad idea! Trump releases video of drone strike on 'drug-carrying' sub Parents’ sarcastic text to daughter, 27, makes point about Gen Z Judge rules Tampa’s ...

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

GSK CEO Emma Walmsley will step down in January, with Luke Miels taking over amidst looming US tariffs on branded pharmaceutical imports. This leadership change comes as GSK navigates critical global ...

GSK announced that its chief executive, Dame Emma Walmsley, will step down at the end of 2025, marking the close of an eight year tenure. She will be succeeded by Luke Miels, currently the company’s ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke Miels — then an executive at rival AstraZeneca Plc — would be “a dream ...

The first woman to helm a Big Pharma will be stepping down in January as GSK’s Emma Walmsley moves aside for her chief commercial officer Luke Miels. Walmsley, 56, who became the British pharma’s CEO ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — GSK on Monday said that Luke Miels, the company’s chief ...